Heart Failure with Preserved Ejection Fraction: Can Device Therapy Be Our Option?

Area of Science:

• Cardiology
• Medical Devices

Background:

• Heart failure with preserved ejection fraction (HFpEF) accounts for half of all heart failure cases.
• HFpEF patients exhibit preserved systolic function but impaired diastolic function, causing heart failure symptoms.
• Despite increased understanding, HFpEF therapies remain limited compared to heart failure with reduced ejection fraction (HFrEF).

Purpose of the Study:

• To review the current applications of device therapy in patients diagnosed with HFpEF.
• To specifically examine the roles of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) in HFpEF management.

Main Methods:

• This is a review article, synthesizing existing literature on device therapy for HFpEF.
• Focus is placed on studies and clinical data concerning ICDs and CRT in the HFpEF population.

Main Results:

• The abstract indicates a focus on device therapy but does not present specific results.
• The review aims to highlight the potential benefits and current limitations of ICDs and CRT in HFpEF.

Conclusions:

• Device therapies, including ICDs and CRT, represent an area of investigation for managing HFpEF.
• Further research and clinical trials are likely needed to establish definitive roles for these devices in HFpEF treatment.